Multinational biopharmaceutical company Polaris Group announced their application for a rolling submission of a new mesothelioma treatment this month. The Biologic License Application…
Johnson & Johnson is trying to resolve some of the thousands of lawsuits filed claiming its talc-based baby powder causes cancer. J&J’s in-house lawyer…
Republican Ohio State Senator George F. Lang is the primary sponsor of a controversial senate bill poised to impact people diagnosed with mesothelioma. The…
Bayer AG was absolved of liability in certain cancer-related lawsuits. The cases concern talc-based foot powders that the company acquired from Merck & Co.
Three educators filed a federal lawsuit against the School District of Philadelphia over their first amendment right to publicly demand answers about asbestos…
A medical researcher responsible for uncovering a potential link between talc and cancer has petitioned a judge to dismiss the lawsuit pharmaceutical giant Johnson…
Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.
If you are looking for mesothelioma support, please contact our Patient Advocates at (855) 404-4592
Who Am I Calling?
Calling this number connects you with a Patient Advocate at The Mesothelioma Center, the nation's most trusted mesothelioma resource.
Our Patient Advocates can help guide you or your loved one through the steps to take after a mesothelioma diagnosis. Our team has a combined experience of more than 30 years in assisting cancer patients, and includes a medical doctor, an oncology registered nurse and a U.S. Navy veteran.
Our fact-checking process begins with a thorough review of all sources to ensure they are high quality. Then we cross-check the facts with original medical or scientific reports published by those sources, or we validate the facts with reputable news organizations, medical and scientific experts and other health experts. Each page includes all sources for full transparency.
Please read our editorial guidelines to learn more about our content creation and review process.
